CSTL CIK: 1447362

Castle Biosciences Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
78.3
FY22:
105
FY23:
175
FY24:
272
FY25:
273
(positive)
Change from FY21 to FY25
millions USD
FY21:
−40.1
FY22:
−72.9
FY23:
−68.0
FY24:
8.67
FY25:
−42.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−36.6
FY22:
–
FY23:
−45.0
FY24:
38.1
FY25:
9.88
(positive)
Change from FY21 to FY25
millions USD
FY21:
−40.0
FY22:
–
FY23:
−57.4
FY24:
21.6
FY25:
−29.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−31.3
FY22:
−67.1
FY23:
−57.5
FY24:
18.2
FY25:
−24.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data